Microsynth
Microsynth AG is a privately held Swiss molecular biology services company, founded in 1989, providing custom DNA/RNA oligonucleotide synthesis and multi-platform sequencing (Sanger, Oxford Nanopore, Illumina) to research institutions, IVD diagnostic manufacturers, and therapeutic developers across Europe.
- Company typePrivate
- Founded1989
- HeadquartersBalgach, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Microsynth does
Microsynth AG is a privately held Swiss life-sciences services company headquartered in Balgach, founded in 1989, with a regional subsidiary (Microsynth France SAS) recently relocated to a new facility in Lyon. The company provides custom DNA and RNA oligonucleotide synthesis alongside multi-platform sequencing services — Sanger (including GMP-compliant), Oxford Nanopore long-read, and Illumina next-generation sequencing — supported by nucleic acid isolation, PCR/qPCR/dPCR assays, and contract research offerings spanning assay development, validation, lot release testing, cell line authentication, mycoplasma testing, CRISPR editing and off-target analysis, and recombinant AAV characterization.
Its core technology stack is built around three instrument platforms and certified chemical synthesis, with ISO 9001, ISO 17025, ISO 13485, and GMP credentials enabling it to serve regulated workflows as well as research use. The portfolio is organized into research, diagnostic, and therapeutic oligonucleotide product lines plus purification (desalt, HPLC, PAGE) and custom fill-and-finish services. A distinct vertically integrated offering — including probe and ASO/siRNA design services — positions Microsynth as a specialty CRO for molecular biology rather than a catalog reagent vendor.
Microsynth operates a B2B sales-led go-to-market targeting three customer segments: research institutions (academic labs and universities — primary), in vitro diagnostic manufacturers, and therapeutic developers (pharmaceutical and biotech companies working on siRNA and ASO preclinical programs). Revenue derives from transactional per-sample fees for sequencing and standard oligos, custom-quote project fees for diagnostic and therapeutic manufacturing, and multi-year contracts for ongoing research support, with distribution split between a self-serve e-commerce shop for smaller buyers and direct enterprise sales supported by technical consultation.
Microsynth firmographics
Firmographics- Name
- Microsynth
- Legal name
- Microsynth AG
- Website
- https://microsynth.ch
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Microsynth AG is a privately held Swiss molecular biology services company, founded in 1989, providing custom DNA/RNA oligonucleotide synthesis and multi-platform sequencing (Sanger, Oxford Nanopore, Illumina) to research institutions, IVD diagnostic manufacturers, and therapeutic developers across Europe.
- Ownership category
- akta.pro rank
Microsynth industry classification
Industry- Product category
- Genomics and Molecular Biology Services
- NAICS
- Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where Microsynth is headquartered
LocationHeadquarters
- HQ city
- Balgach
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Microsynth business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Oligonucleotide Synthesis Services: Custom DNA/RNA oligo synthesis for research, diagnostic, and therapeutic applications with various purification levels (desalted, HPLC, PAGE) and modification options
- Sequencing Services: Sanger sequencing (standard and GMP-compliant), Oxford Nanopore long-read sequencing, and Illumina NGS services charged per sample or per run
- Contract Research Services: Custom assay development, validation, biologics testing, lot release testing, cell line testing, and CRISPR editing analysis
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quotation based on project requirements |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Microsynth product offering
Product offeringCore offering
Microsynth is a Swiss life sciences services company that manufactures custom DNA and RNA oligonucleotides and provides Sanger, Oxford Nanopore, and Illumina sequencing services for research institutions, in vitro diagnostics manufacturers, and therapeutic developers. Its offerings include research oligos, ISO 13485-certified diagnostic oligos, low endotoxin preclinical siRNA and antisense oligonucleotides, contract research, assay development and validation, lot release testing, and certified manufacturing under ISO 9001, ISO 17025, ISO 13485, and GMP standards.
Product overview
Microsynth is a life sciences services company offering a comprehensive portfolio of molecular biology services organized into distinct product lines. The core offerings include: (1) DNA/RNA Oligo Synthesis — spanning research oligonucleotides (DNA oligos, RNA oligos, NGS oligos, PCR/FISH probes, and modifications), diagnostic oligonucleotides (IVD-grade with ISO 13485 certification), therapeutic oligonucleotides (siRNA and antisense oligos for preclinical applications), and custom oligonucleotide projects; (2) Sanger Sequencing Services — including Economy Run, Ecoli NightSeq (direct from colonies), Ready-to-Load Run, Primer Walking Service, and GMP Compliant Sequencing; (3) Oxford Nanopore Sequencing — providing long-read NGS services such as Full PlasmidSeq, Long PCRSeq, BacterialSeq, YeastSeq, nanoCORE Amplicon Metagenomics, De Novo Sequencing, Resequencing, Genomic Epidemiology, and AAV Genome Sequencing; (4) Illumina NGS Services — including miCORE Amplicon Metagenomics, miCORE Whole Genome Metagenomics, miCORE mRNA Sequencing, miCORE Resequencing, Amplicon Deep Sequencing, CRISPR/Cas9 Sequencing, Small RNA Sequencing, and Metatranscriptomics; (5) Isolation and Assaying — covering DNA/RNA isolation, PCR/qPCR/dPCR services, customized assays, food testing assays, fragment length analysis, cell line authentication, and mycoplasma testing; (6) Ecogenics Services — microsatellite marker development, genotyping by microsatellite markers, and genotyping by sequencing (GBS); (7) Contract Research and Outsourcing — including assay development, validation, cross-validation, lot release testing, cell bank testing, and gene therapy support services (CRISPR analysis, off-target analysis, rAAV characterization). The company also offers supplementary services such as purification (desalted, HPLC, PAGE) and custom fill & finish.
Differentiator
Problem solved
Functional benefit
Products and services
- Research Oligonucleotides Custom DNA and RNA oligonucleotides, NGS adapters and indexing primers, PCR and FISH probes, and chemically modified oligos for molecular biology research applications in academic, government, and industrial labs.
- Diagnostic Oligonucleotides (IVD) ISO 13485-certified oligonucleotides and probes for in vitro diagnostics, including PCR/FISH probes and IVD oligos, with probe design services for diagnostic kit manufacturers and companion diagnostic developers.
- Therapeutic Oligonucleotides Low endotoxin siRNA and antisense oligonucleotide (ASO) synthesis for preclinical therapeutic development, including screening siRNAs, screening ASOs, design services, and chemical modifications to enhance stability and efficacy.
- Custom Oligonucleotide Projects Custom-tailored oligonucleotide synthesis projects designed to meet specific customer requirements, including custom purification, fill & finish, hydration and aliquotation, and certificate of analysis services.
- Sanger Sequencing Services DNA sequencing services using Sanger technology, including Economy Run for routine PCR and plasmid samples, Ecoli NightSeq for direct colony sequencing, Ready-to-Load for high-throughput processing, Primer Walking for long fragments, and GMP-compliant sequencing for biologics and diagnostics manufacturing.
- Oxford Nanopore Sequencing Services Long-read next-generation sequencing using Oxford Nanopore Technology for extended read lengths, including Full PlasmidSeq, Long PCRSeq amplicon sequencing, BacterialSeq and YeastSeq genome sequencing, De Novo eukaryotic genome assembly, Resequencing for variant detection, Genomic Epidemiology for pathogen surveillance, AAV genome analysis, and long-read amplicon metagenomics.
- Illumina NGS Services Next-generation sequencing services using Illumina technology for amplicon metagenomics, whole genome metagenomics, 3' mRNA-seq and gene expression analysis, whole genome resequencing, amplicon deep sequencing, CRISPR/Cas9 editing verification, small and microRNA sequencing, and shotgun metatranscriptomics.
- PCR / qPCR / dPCR Services PCR-based services including quantitative PCR (qPCR) and digital PCR (dPCR) for customized assay development and validation, food safety and GMO testing, fragment length and STR analysis, cell line authentication via STR profiling, and PCR-based mycoplasma detection for cell culture quality control.
- Ecogenics Services Specialized genomics services for ecology and breeding applications, including microsatellite marker development, genotyping by microsatellite markers, and high-throughput genotyping by sequencing (GBS).
- Contract Research / Outsourcing Custom contract research and outsourcing services for specialized molecular biology projects, including analytical assay development, validation and cross-validation, biologics lot release testing, cell line and cell bank testing, clinical and pre-clinical sample testing, CRISPR gene editing and off-target analysis, and recombinant AAV (rAAV) vector characterization for gene therapy applications.
- DNA/RNA Isolation Services Nucleic acid isolation service for DNA and RNA extraction from complex biological samples, provided as a feed-in for downstream oligo synthesis, PCR/qPCR/dPCR, and sequencing workflows.
Companies that use Microsynth
Customer profileSegments3 records
Ideal customer profiles4 records
Microsynth technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Microsynth partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Microsynth competitors and assessment
Company assessmentBroad incumbents
- GenScript: GenScript provides gene synthesis, oligonucleotide manufacturing, and cell therapy services globally. Its custom oligo and gene synthesis capabilities overlap with Microsynth's research, diagnostic, and therapeutic service tiers.
- Qiagen (Genomics Services): Qiagen operates a genomics services business delivering sample-to-insight offerings for research and clinical customers. The services overlap Microsynth's nucleic acid isolation, PCR/qPCR, and NGS portions of the portfolio.
- Thermo Fisher Scientific (GeneArt / Custom Oligo Services): Thermo Fisher offers custom oligo synthesis, gene synthesis, and Sanger/NGS services as part of its broader life sciences portfolio. It competes with Microsynth especially on IVD-grade and GMP-grade nucleic acid supply through its extensive commercial channels.
Regional players
- BaseClear: BaseClear is a Dutch molecular biology services lab offering Sanger, NGS, and microbial genomics services. It is comparable to Microsynth's sequencing service line and serves a similar European research and applied market.
Direct peers
- Macrogen: Macrogen is a global DNA sequencing services provider with Sanger and NGS offerings, comparable to Microsynth's sequencing service line. It serves a similar academic and biotech customer base and competes for outsourcing of molecular biology projects.
- Biolegio: Biolegio is a Netherlands-based custom oligonucleotide manufacturer serving research, diagnostic, and therapeutic customers. It is a closely comparable European boutique oligo provider competing for similar IVD and therapeutic clients.
- Integrated DNA Technologies (IDT): IDT (a Danaher company) is a leading global provider of custom DNA/RNA oligonucleotides, including research, diagnostic, and therapeutic-grade products. It competes head-to-head with Microsynth across oligo synthesis, qPCR probes, and GMP nucleic acid manufacturing.
- Eurofins Genomics: Eurofins Genomics is a direct competitor offering custom oligonucleotide synthesis, Sanger sequencing, and NGS services globally. It overlaps Microsynth's full portfolio at industrial scale, including IVD-grade oligo manufacturing under regulatory certifications.
- LGC Biosearch Technologies: LGC Biosearch Technologies provides custom oligonucleotide synthesis, probes, and genomics services for research, diagnostic, and applied markets. It is comparable to Microsynth in target customers (research, IVD, agbio) and technical scope.
Emerging players
- Twist Bioscience: Twist Bioscience is a synthetic biology platform providing DNA synthesis and oligo products at silicon-based scale. While its core is gene synthesis, its oligo and NGS-adapter products directly overlap Microsynth's NGS oligo offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Microsynth social profiles
Digital presenceMicrosynth compliance and trust
Trust signalCompliance6 records
Microsynth financial estimates
Financial estimateRevenue estimate
Valuation estimate
Microsynth leadership team
Management profileNumber of profiles
Microsynth subsidiaries and ownership
Company hierarchySubsidiaries1 record
Microsynth funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Microsynth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Microsynth
What does Microsynth do?
Microsynth is a Swiss life sciences services company that manufactures custom DNA and RNA oligonucleotides and provides Sanger, Oxford Nanopore, and Illumina sequencing services for research institutions, in vitro diagnostics manufacturers, and therapeutic developers. Its offerings include research oligos, ISO 13485-certified diagnostic oligos, low endotoxin preclinical siRNA and antisense oligonucleotides, contract research, assay development and validation, lot release testing, and certified manufacturing under ISO 9001, ISO 17025, ISO 13485, and GMP standards.
Is Microsynth a public or private company?
Microsynth is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Microsynth founded?
Microsynth was founded in 1989. It employs 11 to 50 people.
Where is Microsynth based?
Microsynth is headquartered in Balgach, Switzerland, in the Europe region.
How does Microsynth make money?
Three revenue lines are on record. Oligonucleotide Synthesis Services are the primary driver. The others are sequencing Services and contract Research Services.
Who are Microsynth's main competitors?
Broad incumbents on record are GenScript, Qiagen (Genomics Services) and Thermo Fisher Scientific (GeneArt / Custom Oligo Services). BaseClear is listed as a regional player. Direct peers are Macrogen, Biolegio, Integrated DNA Technologies (IDT), Eurofins Genomics and LGC Biosearch Technologies. Twist Bioscience is listed as an emerging player.
Does Microsynth have an API?
No public API is recorded for Microsynth.
What industry is Microsynth in?
Microsynth's product category is Genomics and Molecular Biology Services. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 5417 and its SIC code is 8071.